GRANTS AND GIVING

Fellowships
Funding provided to support educational clinical programs within healthcare academic organizations in a given area of interest. Alnylam is independent from the selection of the individual Fellow, and the educational institution requesting the funding must demonstrate that it has the infrastructure, expert faculty, curriculum, and ability to design and conduct a successful fellowship program.

Area of Educational Interest
A Clinical Fellowship Grant is intended to support clinical fellowship programs that mentor and advance the training of physicians in the diagnosis, treatment, and research of Transthyretin (ATTR) Amyloidosis. The program will foster multidisciplinary collaboration to improve early recognition, optimize treatment pathways, and accelerate the translation of emerging science into high-quality, patient-centered care.

Application Scope

• Submission Deadline: August 15, 2025
• Notification Date: September 12, 2025
• Fellowship Start and End Dates: July 2026 to June 2027
• Therapeutic Area: Transthyretin-mediated Amyloidosis (ATTR Amyloidosis)
• Geographic Scope: United States

Funding Availability and Requirements

• Individual applicant institution may request up to $95,000 USD that will be considered for funding a one-year clinical Fellowship Program
• Funding may only be used to support salary and Fellow benefits
• Grant funds must not be used for institutional overhead or indirect costs

Applicant Institution Requirements

• Must be an ACGME-accredited U.S. academic institution
• Applicant institution must have an established and active Cardiology Fellowship Program that includes educational interactions with an interdisciplinary team in review of cases and relevant training in ATTR
• Alnylam must not be notified of the name of any potential Fellow during the application process
• Grant funds will be awarded to the institution and not to any individual
• Must execute the Letter of Agreement with Alnylam before the start of the Fellowship Program

Program and Fellow Requirements

• Applicant institution must ensure that the selected Fellow is a U.S. citizen or legal permanent resident
• Applicant institution must ensure that the selected Fellow holds an active M.D. or D.O. license in good standing
• Application must include the details of the Fellowship Program, including but not limited to, a curriculum that includes:
  • Training opportunities with multi-disciplinary teams,
  • Clear methodology for increasing skills and competencies of Fellow, as well as effective monitoring and assessment or the methodology,
  • Fellow engagement in both clinical care and research and/or lab activities, and
  • The program timeline.

Terms and Conditions

• Alnylam does not provide Fellowship Grants for the following activities:
  
  
  1. Grants or payments to individuals, e.g., HCPs or physician group practice organizations;
  2. Organizations or charitable foundations nominated by an HCP;
  3. Fees for the engagement of HCPs or healthcare organizations to provide services;
  4. Organization building funds or equipment;
  5. Website development, promotional programs, religious or social programs, grants to political parties, social events, or charity fundraising;
  6. Research or clinical studies; and
  7. Medical missions to foreign countries and travel grants to US HCPs to attend scientific conferences.
• Alnylam may request supplemental information from applicants, and Alnylam reserves the right to reject incomplete applications.
• Alnylam reserves the right not to fund any request. No grant has been awarded until a formal grant agreement has been fully executed between Alnylam and the applicant organization(s). Application do not commit Alnylam or its affiliates to award a grant of any size, nor to pay any costs incurred in the preparation of a response to this request.
• Alnylam adheres to all applicable U.S. and state spend transparency laws, codes, and regulations, and, as a result, will appropriately report funding related to this grant, when and as required. Alnylam may require receipt of required information in a certain format from recipient organization(s) in order to facilitate disclosure reporting.
• Alnylam reserves the right to verify all information provided by an organization in its grant application.
• Only the Alnylam Grants and Giving Office is authorized to provide information related to any clinical fellowship applications. For questions, please contact grants@alnylam.com

Continuing Medical Education Grants (CME)

These are educational activities developed and executed by independent third party organizations to maintain, develop, or increase the knowledge, skills, and professional performance that a healthcare professional uses to provide services for patients, the public, or the profession. A CME grant is an unsolicited funding request that may be accredited or non-accredited. Alnylam may not receive any tangible business benefit. Transparency of Alnylam’s support is required and is not considered a tangible benefit. Examples might include a live program at a medical conference or an online educational session for CME credit.

Educational Grants (non-CME)

This is funding that is provided in response to an unsolicited request from an eligible third-party organization that has independently applied for grant support for accredited or unaccredited medical education activities or education directed to HCPs, patient organizations, patients, or other members of the health care community. Alnylam may not receive any tangible business benefit. Transparency of Alnylam’s support is required and is not considered a tangible benefit. Examples of a non-CME Educational Grant might include educational videos or newsletters.

Responses to Requests for Proposals

Throughout the year, Alnylam will post Request for Proposals (RFP) to inform organizations and qualified medical education providers that we are interested in receiving requests for independent medical education activities pertinent to Alnylam’s areas of interest and aligned to specifications outlined in our RFPs. The grantee is responsible for the design and execution of the initiative supported by the grant, including compliance with any regulatory requirements. Alnylam may not receive any tangible business benefit. Transparency of Alnylam’s support is required and is not considered a tangible benefit.

When Alnylam receives a tangible business benefit for an event, project or program aimed at educating patients, caregivers, scientists, or healthcare professionals, this is considered a sponsorship.

Examples of sponsorship might include (but are not limited to): corporate memberships, patient advocacy conference support, advertising opportunities, exhibition booths or satellite symposium time slots.

Alnylam may provide monetary or in kind support to charitable organizations to advance science, healthcare, education, or to further other charitable organization goals.

Charitable Donations may be used for philanthropic initiatives or general purposes that support the overall mission of the organization, for example, providing funding after a natural disaster. Alnylam may not receive any tangible business benefit for charitable funding. Transparency of Alnylam’s support is required and is not considered a tangible benefit.